Immunogenicity of Milk Protein-Containing Hydrophilic Gel Patch for Epicutaneous Immunotherapy for Milk Allergy
- 16 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 37 (3), 35
- https://doi.org/10.1007/s11095-019-2728-y
Abstract
Epicutaneous immunotherapy (EPIT) involving the skin’s immune system is easy to use, painless and has a low risk of systemic side effects; it can be applied to food allergies that have a high morbidity rate in children. In this study, we evaluated the safety and efficacy of hydrophilic gel patch (HG) for EPIT.Keywords
This publication has 32 references indexed in Scilit:
- Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patchJournal of Allergy and Clinical Immunology, 2016
- Food allergy: Epidemiology, pathogenesis, diagnosis, and treatmentJournal of Allergy and Clinical Immunology, 2014
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Therapies for allergic inflammation: refining strategies to induce toleranceNature Medicine, 2012
- Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheriaVaccine, 2012
- Immunotherapy for allergic rhinitisClinical & Experimental Allergy, 2011
- Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless ratJournal of Controlled Release, 2011
- Epidemiologic risks for food allergyJournal of Allergy and Clinical Immunology, 2008
- THE HIGH-AFFINITY IgE RECEPTOR (FcεRI): From Physiology to PathologyAnnual Review of Immunology, 1999
- Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1Journal of Allergy and Clinical Immunology, 1997